Velocity’s research site in Norfolk frequently conducts clinical trials related to general medicine, pediatrics and infectious diseases. The site also partners with doctors at Midwest Health Partners, P.C. to conduct studies related to women’s health. Acquired by Velocity in 2022, the Norfolk location was founded in 2013 as part of Meridian Clinical Research. Typical studies at this site involve medications for acne, chronic diseases, depression, high cholesterol, type 2 diabetes, and other conditions. This site also performs vaccine studies for people of all ages. All trials conducted at the site are performed in accordance with ICH and FDA guidelines, and in compliance with GCP.
Located near the city’s health complex, the site is easily accessible to thousands of patients, including those established with Midwest Health Partners and a large Latinx population. Our bi-lingual Norfolk team is committed to being a resource for study participants, to providing the highest quality of patient care with compassion and kindness, and to advancing medicine through research.